News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,020 Results
Type
Article (87035)
Company Profile (704)
Press Release (767269)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232897)
Career Advice (4133)
Deals (39769)
Drug Delivery (131)
Drug Development (91146)
Employer Resources (199)
FDA (18214)
Job Trends (17374)
News (397003)
Policy (39852)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1618)
Antibody-drug conjugate (ADC) (192)
Approvals (18171)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (105)
Brain cancer (44)
Breast cancer (412)
Cancer (3261)
Cardiovascular disease (261)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (599)
Cervical cancer (25)
Clinical research (74553)
Collaboration (1168)
Company closure (3)
Compensation (778)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (405)
Cystic fibrosis (125)
Data (3319)
Decentralized trials (2)
Denatured (55)
Depression (83)
Diabetes (390)
Diagnostics (7009)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (167)
Earnings (98229)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131710)
Executive appointments (930)
FDA (20222)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1049)
Gene editing (154)
Generative AI (42)
Gene therapy (469)
GLP-1 (958)
Government (5299)
Grass and pollen (7)
Guidances (305)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (46)
Immunology and inflammation (197)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (133)
Interviews (813)
IPO (17908)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (62)
Layoffs (608)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (454)
Lymphoma (230)
Machine learning (16)
Management (65)
Manufacturing (492)
MASH (106)
Medical device (14765)
Medtech (14775)
Mergers & acquisitions (22630)
Metabolic disorders (995)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (47)
Neuroscience (2419)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (504)
Opinion (296)
Ovarian cancer (108)
Pain (132)
Pancreatic cancer (136)
Parkinson's disease (206)
Partnered (26)
Patents (346)
Patient recruitment (198)
Peanut (55)
People (65841)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22999)
Phase II (32368)
Phase III (24379)
Pipeline (2008)
Policy (260)
Postmarket research (3554)
Preclinical (10389)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (551)
Real estate (7402)
Recruiting (76)
Regulatory (27375)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (107)
Series A (175)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (951)
Venture capital (62)
Weight loss (342)
Women's health (53)
Worklife (20)
Date
Today (55)
Last 7 days (788)
Last 30 days (2305)
Last 365 days (33767)
2025 (20559)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (72)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50628)
Australia (8895)
California (8243)
Canada (2523)
China (758)
Colorado (352)
Connecticut (367)
Delaware (220)
Europe (116226)
Florida (1229)
Georgia (279)
Hawaii (3)
Idaho (67)
Illinois (763)
India (34)
Indiana (405)
Iowa (19)
Japan (249)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1156)
Massachusetts (6286)
Michigan (282)
Minnesota (515)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (88)
New Hampshire (74)
New Jersey (2294)
New Mexico (31)
New York (2270)
North Carolina (1287)
North Dakota (10)
Northern California (3601)
Ohio (265)
Oklahoma (17)
Oregon (48)
Pennsylvania (1755)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (37)
South Dakota (1)
Southern California (3086)
Tennessee (135)
Texas (1265)
United States (30918)
Utah (241)
Virginia (224)
Washington D.C. (80)
Washington State (716)
West Virginia (4)
Wisconsin (89)
There are 855,020 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
140-Year-Old Boehringer Ingelheim Dives Into Cancer With NSCLC Nod
Phase III data show Hernexeos can elicit a confirmed objective response rate of 48% in patients with HER2-mutated NSCLC who had previously been treated with a directed antibody-drug conjugate.
August 11, 2025
·
2 min read
·
Tristan Manalac
Government
Head MAHA Implementor Fired After RFK Jr.’s mRNA Purge
Gray Delany was pushed out due to disagreements with other top officials over how the Department of Health and Human Services makes its announcements, according to
Endpoints News
.
August 11, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
FDA Restricts Patient Pool for Bluebird’s Skysona Amid Safety Concerns
Skysona can now only be used in patients with cerebral adrenoleukodystrophy who have no available treatment alternatives or stem cell donors.
August 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
IRLAB’s CFO Viktor Siewertz Leaves the Company for a New Leading Position
August 11, 2025
·
2 min read
Press Releases
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
August 11, 2025
·
5 min read
Press Releases
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
August 11, 2025
·
5 min read
Press Releases
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
August 11, 2025
·
9 min read
Press Releases
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
August 11, 2025
·
10 min read
Press Releases
ProBio Launches GMP AAV Manufacturing Services at Hopewell Facility to Advance Gene Therapy Development and Manufacturing
August 11, 2025
·
4 min read
PARTNERED
The Future of Cell and Gene Therapy: Navigating Innovation, Regulation, and Manufacturing Challenges
An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), reveals both promising developments and significant concerns shaping the advanced therapies sector’s trajectory through 2025 and beyond. This interview was conducted with support from
Tozaro
.
August 11, 2025
·
8 min read
·
BioSpace Insights
1 of 85,502
Next
